Gastroesophageal reflux disease: exaggerations, evidence and clinical practice

Cristina Targa Ferreira1, Elisa de Carvalho2, Vera Lucia Sdepanian3

  • 1Pediatric Gastroenterology Service, Hospital da Criança Santo Antônio, Complexo Hospitalar Santa Casa, Porto Alegre, RS, Brazil; Pediatrics Department, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Gastroenterology Department, Sociedade Brasileira de Pediatria, Rio de Janeiro, RJ, Brazil.

Jornal De Pediatria
|November 5, 2013
PubMed

Insights

Diagnosis and treatment of pediatric gastroesophageal reflux disease (GERD) lack evidence, leading to overuse of tests like abdominal ultrasonography and medications such as proton-pump inhibitors (PPIs). Conservative approaches are recommended.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Evidence Review

Background:

  • Gastroesophageal reflux disease (GERD) in children presents diagnostic and therapeutic challenges.
  • Uncertainty exists regarding the association between GERD and cow's milk protein allergy (CMPA), the utility of abdominal ultrasonography, and the overuse of proton-pump inhibitors (PPIs).

Purpose of the Study:

  • To review current scientific evidence for diagnosing and treating GERD in pediatric populations.
  • To clarify ambiguities surrounding GERD management in children.

Main Methods:

  • A comprehensive literature search was performed across major electronic databases (MEDLINE, PubMed, LILACS, SciELO, Cochrane Library).
  • Keywords included "gastroesophageal reflux," "gastroesophageal reflux disease," "proton-pump inhibitors," and "prokinetics" for pediatric age groups up to May 2013.

Main Results:

  • Abdominal ultrasonography is not recommended for diagnosing gastroesophageal reflux (GER).
  • Concurrent treatment of GERD and CMPA may lead to unnecessary medication or dietary interventions.
  • Evidence supporting routine prokinetic use or acid suppression in infants for nonspecific GERD symptoms is insufficient.
  • Conservative treatments offer benefits with low cost and minimal side effects.

Conclusions:

  • Limited randomized controlled trials exist for pediatric GERD management, and no diagnostic test is considered a gold standard.
  • Current practices show potential overdiagnosis and overtreatment of GERD in children, necessitating a reevaluation of diagnostic and therapeutic approaches.
Abstract

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.1K
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
69
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
2.0K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.8K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
1.1K
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.3K